Changchun BCHT Biotechnology Co. (SHA:688276)
20.10
+0.20 (1.01%)
At close: Feb 3, 2026
SHA:688276 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 157.44 | 344.87 | 442.18 | 866.54 | 1,156 | 309.63 |
Cash & Short-Term Investments | 157.44 | 344.87 | 442.18 | 866.54 | 1,156 | 309.63 |
Cash Growth | -43.34% | -22.01% | -48.97% | -25.01% | 273.22% | 13.42% |
Accounts Receivable | 1,183 | 1,407 | 1,567 | 968.41 | 763.94 | 733.18 |
Receivables | 1,183 | 1,407 | 1,567 | 968.41 | 763.94 | 733.18 |
Inventory | 232.4 | 170.78 | 199.02 | 192.11 | 241.34 | 146.19 |
Prepaid Expenses | - | 1.11 | 0.92 | 0.1 | - | - |
Other Current Assets | 62.95 | 41.21 | 35.26 | 30.81 | 29.15 | 32.25 |
Total Current Assets | 1,636 | 1,965 | 2,245 | 2,058 | 2,190 | 1,221 |
Property, Plant & Equipment | 2,568 | 2,478 | 2,085 | 1,642 | 1,439 | 783.08 |
Long-Term Investments | 377.15 | 211.34 | 207.57 | 61.28 | 69.12 | 10.23 |
Other Intangible Assets | 328.26 | 330.6 | 347.45 | 204.02 | 223.72 | 248.57 |
Long-Term Deferred Tax Assets | 140.14 | 96.28 | 90.97 | 54.2 | 31.93 | 20.96 |
Long-Term Deferred Charges | 127.86 | 74.68 | 29.26 | 211.09 | 159.25 | 121.57 |
Other Long-Term Assets | 32.8 | 49.56 | 41.06 | 53.06 | 61.95 | 61.85 |
Total Assets | 5,210 | 5,205 | 5,046 | 4,284 | 4,175 | 2,468 |
Accounts Payable | 25.2 | 13.81 | 17.49 | 24.8 | 63.91 | 34 |
Accrued Expenses | 27.84 | 533.19 | 553.18 | 340.9 | 422.69 | 486.26 |
Short-Term Debt | 204.19 | 42.9 | 20.47 | - | - | - |
Current Income Taxes Payable | 1.98 | - | 48.89 | 5.07 | - | 18.24 |
Current Unearned Revenue | 1.05 | 2.2 | 0.28 | 8.65 | 10.21 | 6.25 |
Other Current Liabilities | 912.63 | 324.97 | 374.56 | 337.27 | 251.89 | 134.94 |
Total Current Liabilities | 1,173 | 917.07 | 1,015 | 716.68 | 748.71 | 679.69 |
Long-Term Debt | 70.42 | 59.93 | - | - | - | - |
Long-Term Unearned Revenue | 8.49 | 9 | 9.86 | 5.92 | 8.09 | 7.88 |
Long-Term Deferred Tax Liabilities | 0.81 | 0.88 | 0.98 | 1.11 | - | - |
Other Long-Term Liabilities | 0 | 0.24 | 0.17 | 0.31 | 0.25 | - |
Total Liabilities | 1,253 | 987.12 | 1,026 | 724.02 | 757.05 | 687.57 |
Common Stock | 413.66 | 413.66 | 412.84 | 412.84 | 412.84 | 371.56 |
Additional Paid-In Capital | 1,817 | 1,840 | 1,820 | 1,778 | 1,771 | 416.29 |
Retained Earnings | 1,761 | 1,989 | 1,819 | 1,380 | 1,240 | 1,023 |
Comprehensive Income & Other | -34.27 | -25.27 | -31.86 | -10.96 | -5.75 | -30.89 |
Shareholders' Equity | 3,958 | 4,218 | 4,020 | 3,560 | 3,418 | 1,780 |
Total Liabilities & Equity | 5,210 | 5,205 | 5,046 | 4,284 | 4,175 | 2,468 |
Total Debt | 274.6 | 102.83 | 20.47 | - | - | - |
Net Cash (Debt) | -117.16 | 242.04 | 421.71 | 866.54 | 1,156 | 309.63 |
Net Cash Growth | - | -42.60% | -51.33% | -25.01% | 273.22% | 186.74% |
Net Cash Per Share | -0.28 | 0.58 | 1.02 | 2.10 | 2.94 | 0.84 |
Filing Date Shares Outstanding | 413.66 | 413.66 | 412.84 | 412.84 | 412.84 | 371.56 |
Total Common Shares Outstanding | 413.66 | 413.66 | 412.84 | 412.84 | 412.84 | 371.56 |
Working Capital | 462.96 | 1,048 | 1,230 | 1,341 | 1,441 | 541.56 |
Book Value Per Share | 9.57 | 10.20 | 9.74 | 8.62 | 8.28 | 4.79 |
Tangible Book Value | 3,629 | 3,887 | 3,673 | 3,356 | 3,194 | 1,531 |
Tangible Book Value Per Share | 8.77 | 9.40 | 8.90 | 8.13 | 7.74 | 4.12 |
Buildings | - | 547.95 | 487.92 | 374.62 | 307.51 | 324.89 |
Machinery | - | 945.72 | 826.34 | 509.79 | 451.85 | 426.37 |
Construction In Progress | - | 1,386 | 1,101 | 1,038 | 919.84 | 235.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.